SCHEMBL4124338

SCHEMBL4124338

COc1cccc(C(O)c2cc(Cl)ccc2NC(=O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
MAPT P10636 2/20 0.47
PKM P14618 1/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
GRIK1 P39086 1/20 0.46
LMNA P02545 3/20 0.44
RECQL P46063 1/20 0.44
KDM4E B2RXH2 1/20 0.44
HPGD P15428 1/20 0.44
GFER P55789 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.43
ALDH1A1 P00352 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
LPAR1 Q92633 2/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13776429 0.85 MEN1 (0.47) MEN1KMT2AMAPTPKMHTT
SCHEMBL13776050 0.85 MEN1 (0.46) MEN1KMT2AMAPTPKMHTT
SCHEMBL4134040 0.81 LPAR1 (0.49) MEN1KMT2AMAPTPKMHTT
SCHEMBL4122916 0.79 LPAR1 (0.56) MEN1KMT2AMAPTSMN1; SMN2GRIK1
SCHEMBL4125868 0.79 LPAR1 (0.50) MEN1KMT2AMAPTSMN1; SMN2GRIK1
SCHEMBL4116747 0.79 LPAR1 (0.45) MEN1KMT2AMAPTPKMHTT
SCHEMBL4123090 0.79 LPAR1 (0.50) MEN1KMT2AMAPTSMN1; SMN2GRIK1
SCHEMBL3256221 0.77 AOC3 (0.46) MEN1KMT2APKMHTTSMN1; SMN2
SCHEMBL4124228 0.77 LPAR1 (0.43) MEN1KMT2AMAPTPKMHTT
SCHEMBL4129998 0.77 LPAR1 (0.48) MEN1KMT2AMAPTSMN1; SMN2GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR MEN1 2041/4885KMT2A 1467/4885MAPT 4428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.